BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22145009)

  • 1. Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.
    Ono J; Yaeger KA; Genevay M; Mino-Kenudson M; Brugge WR; Pitman MB
    Cytojournal; 2011; 8():21. PubMed ID: 22145009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.
    Genevay M; Mino-Kenudson M; Yaeger K; Konstantinidis IT; Ferrone CR; Thayer S; Castillo CF; Sahani D; Bounds B; Forcione D; Brugge WR; Pitman MB
    Ann Surg; 2011 Dec; 254(6):977-83. PubMed ID: 22041510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
    Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
    Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than "positive" cytology.
    Pitman MB; Genevay M; Yaeger K; Chebib I; Turner BG; Mino-Kenudson M; Brugge WR
    Cancer Cytopathol; 2010 Dec; 118(6):434-40. PubMed ID: 20931638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
    Anand N; Sampath K; Wu BU
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
    Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions.
    Pitman MB; Michaels PJ; Deshpande V; Brugge WR; Bounds BC
    Pancreatology; 2008; 8(3):277-84. PubMed ID: 18497541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
    JOP; 2014 Sep; 15(5):459-64. PubMed ID: 25262713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.
    Pitman MB; Centeno BA; Daglilar ES; Brugge WR; Mino-Kenudson M
    Cancer Cytopathol; 2014 Jan; 122(1):40-7. PubMed ID: 23939829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
    Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison with surgically resected mucinous cystic neoplasm of pancreas and branch-duct type intraductal papillary mucinous neoplasm considering clinico-radiological high-risk features: a reassessment of current guidelines.
    Kim H; Kim JH; An J; Choi JS
    Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38744705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
    Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
    Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.